Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of solid cancer overall. More than 95% of GBM patients die within 5 years after diagnosis. Accumulating evidence indicates that cannabinoids have potent anti-tumor functions.
Glioblastoma...
Half of newly-diagnosed gliomas are glioblastomas (GBMs), with an incidence in adults of 0.59 3.69 cases per 100,000 person life-years. Primary GBM occur more commonly in male patients whereas the reverse is the case for secondary GBM. The mean age of primary and secondary G BM patients is 62 and 45 years, respectively (Adamson et al., 2009).
Cannabinoids...
The term cannabinoids originally described bioactive constituents of the plant Cannabis sativa. The cannabis ingredients were used traditionally for their medicinal purpose but also for their recreational properties. Most of the cannabinoids bind to G-protein coupled cannabinoid receptors, CB1 and CB2, and act as agonists or inverse agonists.